China Pharma Announced the Submission of a Plan of Compliance to NYSE American
- Monday, July 18, 2022, 7:00
- Finance
- Add a comment
HAIKOU, China, July 18, 2022 /PRNewswire/ — China Pharma Holdings, Inc. (NYSE American: CPHI) (“China Pharma,” the “Company” or “We”), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC (“NYSE…
About the Author
adminasapcorp has written 41562 stories on this site.